GlassScriptPhysician profile
Mark W Vogel
NPI 1578653457
$7,034.86
in general payments reported to CMS, 2019-2025
44 companies · $962 in 2025
The $962 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,901 · 2020: $693 · 2021: $691 · 2022: $1,056 · 2023: $811 · 2024: $922 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,693.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $861.09 | 2019-2024 | Myrbetriq, Xtandi |
| Abbvie INC. | $723.49 | 2019-2024 | Botox |
| Procept Biorobotics Corporation | $501.04 | 2022-2025 | Aquabeam System |
| Teleflex LLC | $429.59 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $385.20 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $367.54 | 2022-2025 | Rybrevant, Carvykti, Erleada |
| Antares Pharma, INC. | $354.09 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Urogen Pharma, INC. | $305.16 | 2021-2025 | Jelmyto |
| Blue Earth Diagnostics | $288.81 | 2019-2024 | |
| Pfizer INC. | $252.10 | 2019-2024 | |
| Biotissue Holdings INC. | $246.14 | 2022-2024 | |
| Baxter Healthcare | $245.10 | 2023-2025 | Starling System, Floseal, Tisseel |
| Acerus Pharmaceuticals Corporation | $225.54 | 2020-2022 | |
| Amgen INC. | $179.87 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $177.69 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.